Innoviva Inc. (INVA)
NASDAQ: INVAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
INVA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.52B
- P/E (TTM)
- 4.92
- Forward P/E
- 9.53
- EPS (TTM)
- $4.28
- Dividend yield
- None
- Ex-dividend date
- Sep 8, 2015
- 52-week range
- 16.52 – 25.15
- Day range
- 20.78 – 21.10
- Volume / Avg
- 636.35K / 825.31K
- Beta
- —
- Shares outstanding
- 72.25M
- Next earnings
- Nov 4, 2026
52-week range
INVA stock today
On Oct 7, INVA ended the session at $21.06, adding $0.23 (1.10%), versus the S&P 500's 0.22% decline. At this level, INVA sits in the middle of its 52-week range of $16.52 to $25.15: 16.3% below the high, set on Feb 26, 2026 and 27.5% above the low. INVA is up 5.4% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 22.4%.
Innoviva trades at 4.9x its trailing twelve-month earnings per share of $4.28. Its forward P/E of 9.5x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year. Innoviva's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Innoviva
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2004
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $0.49
Dividends
Dividend history- Annual dividend
- $0.00
- Last payment
- $0.25
- Ex-dividend date
- Sep 8, 2015
Innoviva peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SNDXSyndax Pharmaceuticals Inc. | 17.03 | -1.96% | $1.52B | vs INVA |
| RAPPRapport Therapeutics Inc. | 30.86 | -0.93% | $1.48B | vs INVA |
| PAHCPhibro Animal Health Corporation Class A | 37.72 | +3.03% | $1.53B | vs INVA |
| RAREUltragenyx Pharmaceutical Inc. | 14.89 | +2.97% | $1.47B | vs INVA |
| GHRSGH Research PLC | 21.06 | -2.14% | $1.45B | vs INVA |
| STOKStoke Therapeutics Inc. | 24.29 | -0.33% | $1.57B | vs INVA |
| KRSAKorsana Biosciences Inc. | 31.65 | -0.38% | $1.44B | vs INVA |
| ETONEton Pharmaceuticals Inc. | 54.88 | +0.20% | $1.57B | vs INVA |
Indexes, lists and sector
Appears in lists
Innoviva stock FAQ
What is Innoviva's stock price today?
INVA last traded at $21.06 as of Oct 7, 4:00 PM EDT, up 1.10% on the day. Prices are delayed at least 15 minutes.
Does Innoviva pay a dividend?
Yes. Innoviva pays $0.00 per share annually. The most recent dividend of $0.25 had an ex-dividend date of Sep 8, 2015.
When is Innoviva's next earnings date?
Innoviva is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $0.49.
What is INVA's P/E ratio?
INVA trades at a trailing P/E ratio of 4.92 and a forward P/E of 9.53.
Has INVA ever split its stock?
Yes. The most recent INVA stock split was a 1241-for-1000 split on Jun 3, 2014.
What is the INVA 52-week high?
The 52-week high for INVA is $25.15 and the 52-week low is $16.52. The stock is currently 16.3% below its high.